CN Patent
CN114280182A — 一种太子参均一多糖的hplc-fld检测方法
Assigned to FUJIAN COLLEGE OF TRADITIONAL CHINESE MEDICINE · Expires 2022-04-05 · 4y expired
What this patent protects
本发明公开了一种太子参均一多糖的HPLC‑FLD检测方法,用2‑氨基联苯胺对太子参均一多糖进行荧光标记,以葡聚糖为标准品,采用HPLC‑FLD定量分析太子参均一多糖,用于生物样本细胞培养液中太子参均一多糖的测定。方法简单、灵敏、准确,应用前景广阔。
USPTO Abstract
本发明公开了一种太子参均一多糖的HPLC‑FLD检测方法,用2‑氨基联苯胺对太子参均一多糖进行荧光标记,以葡聚糖为标准品,采用HPLC‑FLD定量分析太子参均一多糖,用于生物样本细胞培养液中太子参均一多糖的测定。方法简单、灵敏、准确,应用前景广阔。
Drugs covered by this patent
- Zavesca (MIGLUSTAT) · AstraZeneca
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.